Rxcurve
HCPCS J1190 · per 250 MG

Dexrazoxane hcl injection

Products billed under this code include Dexrazoxane.

Payment limit per 250 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J1190

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Dexrazoxane Hikma Pharmaceuticals USA Inc. 00143-9247-01 1 $30.832
Dexrazoxane Hikma Pharmaceuticals USA Inc. 00143-9248-01 2 $61.664
Dexrazoxane Eugia US LLC 55150-0434-01 1 $30.832
Dexrazoxane Eugia US LLC 55150-0434-02 1 $30.832
Dexrazoxane Eugia US LLC 55150-0437-01 2 $61.664
Dexrazoxane Novadoz Pharmaceuticals LLC 72205-0247-01 1 $30.832
Dexrazoxane Novadoz Pharmaceuticals LLC 72205-0248-01 2 $61.664
Dexrazoxane Fosun Pharma USA Inc. 72266-0101-01 2 $61.664
Dexrazoxane Fosun Pharma USA Inc. 72266-0235-01 1 $30.832
Dexrazoxane Almaject, Inc. 72611-0716-01 2 $61.664
Show all 11 products
ProductLabelerNDCUnits / pkgLimit / pkg
Dexrazoxane Almaject, Inc. 72611-0716-72 2 $61.664

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $30.832 −$10.609 250 MG Dexrazoxane hcl injection v1, posted September 17, 2026
3Q26 $41.441 −$8.297 250 MG Dexrazoxane hcl injection v1, posted September 15, 2026
2Q26 $49.738 −$8.275 250 MG Dexrazoxane hcl injection v1, posted September 15, 2026
1Q26 $58.013 −$5.047 250 MG Dexrazoxane hcl injection v1, posted September 15, 2026
4Q25 $63.06 +$30.975 250 MG Dexrazoxane hcl injection v1, posted September 8, 2026
3Q25 $32.085 −$48.871 250 MG Dexrazoxane hcl injection v1, posted March 10, 2026
2Q25 $80.956 +$0.081 250 MG Dexrazoxane hcl injection v1, posted March 10, 2026
1Q25 $80.875 −$6.619 250 MG Dexrazoxane hcl injection v1, posted December 19, 2025
4Q24 $87.494 −$13.171 250 MG Dexrazoxane hcl injection v1, posted June 11, 2025
3Q24 $100.665 +$9.575 250 MG Dexrazoxane hcl injection v1, posted June 11, 2025
2Q24 $91.09 −$16.916 250 MG Dexrazoxane hcl injection v1, posted March 11, 2025
1Q24 $108.006 −$15.873 250 MG Dexrazoxane hcl injection v1, posted December 19, 2024
4Q23 $123.879 +$9.982 250 MG Dexrazoxane hcl injection v1, posted October 10, 2024
3Q23 $113.897 −$53.019 250 MG Dexrazoxane hcl injection v1, posted June 5, 2024
2Q23 $166.916 +$41.663 250 MG Dexrazoxane hcl injection v1, posted February 23, 2024
1Q23 $125.253 −$31.448 250 MG Dexrazoxane hcl injection v1, posted December 6, 2023
4Q22 $156.701 −$12.082 250 MG Dexrazoxane hcl injection v1, posted June 22, 2023
3Q22 $168.783 −$12.433 250 MG Dexrazoxane hcl injection v1, posted June 9, 2023
2Q22 $181.216 −$8.627 250 MG Dexrazoxane hcl injection v1, posted December 14, 2022
1Q22 $189.843 −$2.487 250 MG Dexrazoxane hcl injection v1, posted June 8, 2022
4Q21 $192.33 −$2.649 250 MG Dexrazoxane hcl injection v1, posted June 2, 2022
3Q21 $194.979 −$12.513 250 MG Dexrazoxane hcl injection v1, posted June 2, 2022
2Q21 $207.492 +$11.509 250 MG Dexrazoxane hcl injection v1, posted March 1, 2022
1Q21 $195.983 – 250 MG Dexrazoxane hcl injection v1, posted December 10, 2021

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files